Literature DB >> 28419427

How I manage children with neutropenia.

David C Dale1.   

Abstract

Neutropenia, usually defined as a blood neutrophil count <1·5 × 109 /l, is a common medical problem for children and adults. There are many causes for neutropenia, and at each stage in life the clinical pattern of causes and consequences differs significantly. I recommend utilizing the age of the child and clinical observations for the preliminary diagnosis and primary management. In premature infants, neutropenia is quite common and contributes to the risk of sepsis with necrotizing enterocolitis. At birth and for the first few months of life, neutropenia is often attributable to isoimmune or alloimmune mechanisms and predisposes to the risk of severe bacterial infections. Thereafter when a child is discovered to have neutropenia, often associated with relatively minor symptoms, it is usually attributed to autoimmune disorder or viral infection. The congenital neutropenia syndromes are usually recognized when there are recurrent infections, the neutropenia is severe and there are congenital anomalies suggesting a genetic disorder. This review focuses on the key clinical finding and laboratory tests for diagnosis with commentaries on treatment, particularly the use of granulocyte colony-stimulating factor to treat childhood neutropenia.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  childhood neutropenia; congenital neutropenia; granulocyte colony stimulating factor; neonatal neutropenia; neutropenia

Mesh:

Substances:

Year:  2017        PMID: 28419427     DOI: 10.1111/bjh.14677

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

1.  SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicing.

Authors:  Christoph Schürch; Thorsten Schaefer; Joëlle S Müller; Pauline Hanns; Marlon Arnone; Alain Dumlin; Jonas Schärer; Irmgard Sinning; Klemens Wild; Julia Skokowa; Karl Welte; Raphael Carapito; Seiamak Bahram; Martina Konantz; Claudia Lengerke
Journal:  Blood       Date:  2021-03-11       Impact factor: 22.113

2.  Primary autoimmune neutropenia of infancy and childhood in a cohort of patients from western Romania.

Authors:  Cristian Jinca; Margit Serban; Emilia Ursu; Andrei Munteanu; Smaranda Arghirescu
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

3.  Antibiotic-Induced Neutropenia During Treatment of Hematogenous Osteoarticular Infections in Otherwise Healthy Children.

Authors:  Krystian Solis; Walter Dehority
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Sep-Oct

4.  Diagnosis and therapeutic decision-making for the neutropenic patient.

Authors:  James A Connelly; Kelly Walkovich
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

5.  Neonatal Immune Neutropenia due to Isoantibodies against the Granulocyte Receptor FcγRIIIb.

Authors:  Beatriz Valle Del Barrio; Silvia Maya-Enero; J J Rodríguez-Sevilla; Carme Canals Surís; Alba Bosch Llobet; María Ángeles López-Vílchez
Journal:  Transfus Med Hemother       Date:  2021-02-25       Impact factor: 3.747

6.  Antibiotic-Induced Neutropenia in Pediatric Patients: New Insights From Pharmacoepidemiological Analyses and a Systematic Review.

Authors:  Vera Battini; Alessandra Mari; Michele Gringeri; Francesca Casini; Francesco Bergamaschi; Giulia Mosini; Greta Guarnieri; Marco Pozzi; Maria Nobile; Gianvincenzo Zuccotti; Emilio Clementi; Sonia Radice; Valentina Fabiano; Carla Carnovale
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

Review 7.  Vaccination in children with chronic severe neutropenia - review of recommendations and a practical approach.

Authors:  Szymon Janczar; Beata Zalewska-Szewczyk; Katarzyna BąBOL-Pokora; JarosŁaw PaŚnik; Krzysztof Zeman; Wojciech MŁynarski
Journal:  Cent Eur J Immunol       Date:  2020-07-27       Impact factor: 2.085

8.  The clinical outcomes and biomarker features of severe sepsis/septic shock with severe neutropenia: a retrospective cohort study.

Authors:  Fan Yin; Yue-Ling Xi; Ying Wang; Bi-Ru Li; Juan Qian; Hong Ren; Jian Zhang; Hong-Zhi Tang; Bo-Tao Ning
Journal:  Transl Pediatr       Date:  2021-03

9.  Expression of Somatostatin Receptor Subtypes (SSTR-1-SSTR-5) in Pediatric Hematological and Oncological Disorders.

Authors:  Kristof Harda; Zsuzsanna Szabo; Eva Juhasz; Balazs Dezso; Csongor Kiss; Andrew V Schally; Gabor Halmos
Journal:  Molecules       Date:  2020-12-07       Impact factor: 4.411

10.  Reduction in White Blood Cell, Neutrophil, and Red Blood Cell Counts Related to Sex, HLA, and Islet Autoantibodies in Swedish TEDDY Children at Increased Risk for Type 1 Diabetes.

Authors:  Falastin Salami; Hye-Seung Lee; Eva Freyhult; Helena Elding Larsson; Åke Lernmark; Carina Törn
Journal:  Diabetes       Date:  2018-08-13       Impact factor: 9.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.